Real-Time, In Vivo Measurement of Radiation Dose during Radioimmunotherapy in Mice Using a Miniature MOSFET Dosimeter Probe

1995 ◽  
Vol 141 (3) ◽  
pp. 330 ◽  
Author(s):  
David J. Gladstone ◽  
Lee M. Chin
2009 ◽  
Vol 23 (3) ◽  
pp. 373-378 ◽  
Author(s):  
Sero Andonian ◽  
Tonya Coulthard ◽  
Arthur D. Smith ◽  
Pravin S. Singhal ◽  
Benjamin R. Lee

2013 ◽  
Vol 25 (7) ◽  
pp. 1757-1763 ◽  
Author(s):  
Nuno R. Ferreira ◽  
Ricardo M. Santos ◽  
João Laranjinha ◽  
Rui M. Barbosa

2009 ◽  
Vol 181 (4S) ◽  
pp. 807-807
Author(s):  
Sero Andonian ◽  
Tonya Coulthard ◽  
Pravin S Singhal ◽  
Arthur D Smith ◽  
Benajamin R Lee

2005 ◽  
Vol 48 (spe2) ◽  
pp. 215-220 ◽  
Author(s):  
Bernardo Maranhão Dantas ◽  
Ana Letícia Almeida Dantas ◽  
Fábio Luiz Navarro Marques ◽  
Luiz Bertelli ◽  
Michael G. Stabin

99mTc is a radionuclide widely used for imaging diagnosis in nuclear medicine. In Brazil it is obtained by elution from 99Mo-99mTc generators supplied by the Nuclear Energy Research Institute (IPEN). The elution is carried out in radiopharmacy laboratories located in hospitals and clinics. Depending of the quality of the generator and conditions of use during the elution process, 99Mo can be extracted from the column of the generator, becoming a radionuclidic impurity of the eluate used for the obtention of the radiopharmaceutical to be administered to the patient. 99Mo emits high-energy photons and beta particles and its presence degrades the quality of the image and unnecessarily increases the radiation dose delivered to the patient. An in-vivo measurement technique was developed to verify the occurrence of internal contamination by 99Mo in nuclear medicine patients. Direct measurements were made in a volunteer who underwent myocardial scintigraphy with 99mTc-sestamibi. The results indicated the presence of internal contamination of the patien by 99Mot. The activity was tracked for several days, and an assessment of the radiation dose from the contaminant 99Mo was made.


2022 ◽  
Author(s):  
Peter S Johnstone ◽  
Maite Ogueta ◽  
Inan Top ◽  
Sheyum Syed ◽  
Ralf Stanewsky ◽  
...  

Circadian clocks are highly conserved transcriptional regulators that control 24-hour oscillations in gene expression, physiological function, and behavior. Circadian clocks exist in almost every tissue and are thought to control tissue-specific gene expression and function, synchronized by the brain clock. Many disease states are associated with loss of circadian regulation. How and when circadian clocks fail during pathogenesis remains largely unknown because it is currently difficult to monitor tissue-specific clock function in intact organisms. Here, we developed a method to directly measure the transcriptional oscillation of distinct neuronal and peripheral clocks in live, intact Drosophila, which we term Locally Activatable BioLuminescence or LABL. Using this method, we observed that specific neuronal and peripheral clocks exhibit distinct transcription properties. Loss of the receptor for PDF, a circadian neurotransmitter critical for the function of the brain clock, disrupts circadian locomotor activity but not all tissue-specific circadian clocks; we found that, while peripheral clocks in non-neuronal tissues were less stable after the loss of PDF signaling, they continued to oscillate. This result suggests that the presumed dominance of the brain clock in regulating peripheral clocks needs to be re-examined. This result further demonstrates that LABL allows rapid, affordable, and direct real-time monitoring of clocks in vivo.


1995 ◽  
Vol 10 (7) ◽  
pp. 1638-1641 ◽  
Author(s):  
Y. Paltieli ◽  
A. Weichselbaum ◽  
N. Hoffman ◽  
I. Eibschitz ◽  
Z. Kam

Sign in / Sign up

Export Citation Format

Share Document